Clinical trials with reno-vascular end points in patients with diabetes: Changing the scenario over the past 20 years.

Block, Tomasz J; Cooper, Mark E

Block, Tomasz J; Cooper, Mark E.

Block TJ; Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Cooper ME; Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia. Electronic address: Mark.Cooper@monash.edu.

Presse Med ; 52(1): 104178, 2023 Mar.

Article en En | MEDLINE | ID: mdl-37783423

Asunto(s)

Diabetes Mellitus Tipo 2; Nefropatías Diabéticas; Inhibidores del Cotransportador de Sodio-Glucosa 2; Humanos; Nefropatías Diabéticas/tratamiento farmacológico; Riñón; Inhibidores del Cotransportador de Sodio-Glucosa 2/uso terapéutico; Glucosa; Diabetes Mellitus Tipo 2/tratamiento farmacológico

Palabras clave

Diabetic complications; Diabetic kidney disease; Diabetic nephropathy; Prevention; Renoprotection; Therapeutic targets

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google